Dr. Agarwal’s Eye Hospital Ltd, a 68-year-old healthcare company, is now managed by Prof. Amar Agarwal (Chairman), Dr. Athiya Agarwal (Director), Dr. Adil Agarwal (CEO), and a workforce of more than 1,133 people. The company offers various eye treatment facilities, including Cataract, Fungal Keratitis, Diabetic Retinopathy, Macular Edema, and Blepharitis, among others. They have a global presence in 10 countries with 250-plus eye hospitals. They have grown by over 2000% in their share price in the last 5 years. However, their revenue is 402 crore, and net income is 54 crore for FY 2024-25.

Establishment

Chennai in 1957 by Dr. Jaiveer Agarwal and Dr. Tahira Agarwal

Website

https://www.dragarwal.com

Company Listed On

National Stock Exchange (NSE) and Bombay Stock Exchange (BSE)

Core Business

A network of eye hospitals and clinics

Financial Performance

It has a positive revenue growth and profit margin

Future Outlook

1. Acquisition of new hospitals/clinics
2. Growing demand for eye care services
3. Drive in ageing population and increased number of lifestyle-related vision issues
4. Integration of advanced technologies in the services
5. Strong investment backup

Disclaimer:

Unsold 70 publishes research-based articles to help readers understand businesses and the stock market. Dr Agarwal’s Eye Hospital Ltd company profile is not investment recommendation as past performance does not guarantee future results. You should perform your own research and seek advice from a SEBI-registered financial advisor before making investment decisions.